首页> 外文会议>Annual International Conference on Research in Computational Molecular Biology >AptaBlocks: Accelerating the Design of RNA-Based Drug Delivery Systems
【24h】

AptaBlocks: Accelerating the Design of RNA-Based Drug Delivery Systems

机译:Aptablocks:加速基于RNA的药物递送系统的设计

获取原文

摘要

Synthetic RNA molecules are increasingly used to alter cellular functions [1-4]. These successful applications indicate that RNA-based therapeutics might be able to target currently undruggable genes [5, 6]. However, to achieve this promise, an effective method for delivering therapeutic RNAs into specific cells is required. Recently, RNA aptamers emerged as promising delivery agents due to their ability of binding specific cell receptors [7, 8]. Crucially, these aptamers can frequently be internalized into the cells expressing these receptors on their surfaces. This property is leveraged in aptamer based drug delivery systems by combining such receptor-specific aptamers with a therapeutic "cargo" such that the aptamer facilitates the internalization of the cargo into the cell [9-11]. The advancement of this technology however is contingent on an efficient method to produce stable molecular complexes that include specific aptamers and cargoes. A recently proposed experimental procedure for obtaining such complexes relies on conjugating the aptamer and the cargo with complementary RNA strands so that when such modified molecules are incubated together, the complementary RNA strands hybridize to form a double-stranded "sticky bridge" connecting the aptamer with its cargo [12, 13]. However, designing appropriate sticky bridge sequences guaranteeing the formation and stability of the complex while simultaneously not interfering with the aptamer or the cargo as well as not causing spurious aggregation of the molecules during incubation has proven highly challenging.
机译:合成RNA分子越来越多地用于改变细胞功能[1-4]。这些成功的应用表明基于RNA的治疗方法可能能够靶向目前不可驾命的基因[5,6]。然而,为了实现这一承诺,需要一种将治疗性RNA递送到特定细胞中的有效方法。最近,由于其结合特异性细胞受体的能力[7,8],RNA适体作为有前途的递送剂而出现的递送剂。至关重要,这些适体可以经常被内化到其表面上表达这些受体的细胞中。该特性通过将这些受体特异性适体与治疗性“货物”组合来利用该特性,使得适体促进货物内化进入细胞[9-11]。然而,这种技术的进步是对产生稳定的分子复合物的有效方法,包括特异性适体和货物。最近提出的用于获得这些复合物的实验程序依赖于将适体和货物与互补的RNA链缀合,使得当将这种修饰的分子孵育在一起时,互补的RNA链杂交以形成连接适体的双链的“粘性桥”。它的货物[12,13]。然而,设计适当的粘性桥序列,保​​证了复合物的形成和稳定性,同时不干扰适体或货物,也没有引起孵育期间分子的杂散聚集已经证明具有高度挑战性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号